Analysts struggled to predict Anthem-Cigna outcome (but don’t tell them that)
The proposed $48 billion merger of Anthem and Cigna kept Wall Street experts guessing for months.
The proposed $48 billion merger of Anthem and Cigna kept Wall Street experts guessing for months.
Anthem says it is giving up on the $48 billion purchase in the wake of a Thursday court ruling giving Cigna the right to walk away. The Indianapolis-based insurer says Cigna is not entitled to collect a $1.85 billion breakup fee.
Lilly is in a race with several pharmaceutical firms to develop migraine treatments using an approach known as anti-CGRP and that could create a multibillion-dollar market.
The decision makes it virtually impossible for Anthem to salvage the merger and means the insurer could be on the hook for $1.85 billion in breakup fees and $13 billion in damages to Cigna.
Dr. John Steenbergen admitted he had a sexual relationship with a patient for five years and performed an abortion on her, but said the licensing board unfairly characterized the matter.
Carmel-based insurer Baldwin & Lyons Inc. wrote a record amount of premiums in its latest quarter, but overall profit dropped compared to the previous year.
Aetna has said it expects to lose more than $200 million on individual health plans this year in the four states where it’s still selling Affordable Care Act plans.
Health insurers are asking for sharp increases in the cost of their Obamacare plans next year. In the first states to make the latest rates public, premiums for Affordable Care Act plans will rise more than 20 percent on average.
Judge Travis Laster said during a hearing Monday that it’s a “long shot” that Anthem can find a path to success after two federal courts found the $48 billion merger was crippled by antitrust problems.
The lobby group, Pharmaceutical Research and Manufacturers of America—which counts Eli Lilly and Co. as a member—is proposing that to remain a member, companies will have to spend $200 million a year on research and development.
Founded in 2006, Fast BioMedical Inc. plans to use the money to help advance clinical trials and hire additional workers. It develops technologies to measure blood volume and kidney function.
Health insurer Anthem Inc. is not ready to give up its $48 billion bid for rival Cigna and now hopes to find a favorable audience in the U.S. Supreme Court.
PolicyStat LLC, an 11-year-old Carmel-based software-as-a-service company, has been acquired by Bridgewater, New Jersey-based iContracts Inc.
State Farm Mutual Automobile Insurance Co. said it plans to shut down 11 U.S. facilities, including its operations centers in Indianapolis and West Lafayette, displacing 620 people in Indiana and 4,200 workers overall.
Oakland University in suburban Detroit on Thursday announced that its board of trustees unanimously chose Ora Hirsch Pescovitz for the job after a search involving more than 60 candidates.
Around Indiana, life sciences companies are searching high and low for venture capital to fund promising but expensive new products, which can take a decade or longer to develop.
Here is a sampling of panelists’ comments at the April 28 Life Sciences Power Breakfast.
The measure skirted through the House by a 217-213 vote, as all voting Democrats and a group of mostly moderate Republican holdouts voted no.
Republicans began pushing their prized health care bill through the House on Thursday, as the GOP sought a victory for President Donald Trump six weeks after nearly leaving the measure for dead.
Analysts say either Anthem or Cigna could make a move on Humana, which specializes in the fast-growing business of selling private health plans for the elderly.